Skip to main content
. 2011 Mar 8;2011:624691. doi: 10.4061/2011/624691

Table 3.

PAC PRA PAC/PRA
Medications
β-Adrenergic blockers ↓↓ ↑(FP)
 Central α-2 agonists ↓↓ ↑(FP)
 NSAIDs ↓↓ ↑(FP)
 K+-wasting diuretics →↑ ↑↑ ↓(FN)
 K+-sparing diuretics ↑↑ ↓(FN)
 ACE inhibitors ↑↑ ↓(FN)
 ARBs ↑↑ ↓(FN)
 Ca2+ blockers (DHPs) →↓ ↓(FN)
 Renin inhibitors ↓↑1 ↑(FP)1
↓ (FN) 1
Potassium status
 Hypokalemia →↑ ↓(FN)
 Potassium loading →↓ ↑(FP)
Dietary sodium
 Sodium restricted ↑↑ ↓(FN)
 Sodium loaded ↓↓ ↑(FP)
Advancing age ↓↓ ↑ (FP)
Other conditions
 Renal impairment ↑(FP)
 PHA-2 ↑(FP)
 Pregnancy ↑↑ ↓(FN)
 Renovascular HTN ↑↑ ↓(FN)
 Malignant HTN ↑↑ ↓ (FN)